RAP 0.00% 20.5¢ resapp health limited

Ann: Release of Restricted Securities, page-141

  1. 26,724 Posts.
    lightbulb Created with Sketch. 1732
    I think there was only 1-2 week delay in reaching the clinical trials target due to the slow pneumonia season effecting the recruitment numbers in the US, but I agree, from memory, they have always said FDA submission in July which is still on target if the top-line results are finalized in the next 1-2 weeks, given it's been already 2 weeks since they've closed the recruitment as target has been meant.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.